Kuwait vs New Zealand: Treatment success rate for patients treated for MDR-TB
Kuwait
100.0%
in 2021
New Zealand
100.0%
in 2022
Kuwait rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Kuwait
- New Zealand
How they compare
Kuwait currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 8 times across 14 shared years of data; in 2002 it was New Zealand ahead.
Kuwait ranks 1st and New Zealand ranks 1st of 163 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.7% | 50.0% | 6.7% | Kuwait |
| 2010s | 73.1% | 68.4% | 4.7% | Kuwait |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kuwait or New Zealand?
- Kuwait, at 100.0% against 100.0% in New Zealand as of 2021.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kuwait and New Zealand?
- 0.0%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and New Zealand?
- 14 years are reported by both, from 2002 to 2021.
- How do Kuwait and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Kuwait ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.